Targeted Therapies Drive the Global Renal Cell Carcinoma (RCC) Drugs Market ... San Francisco Chronicle (press release) Additionally, growth is also expected to stem from the introduction of new emerging therapies, increased use of combination therapies, and introduction of other drug classes, such as mTOR inhibitors. San Jose, California (PRWEB) May 07, 2012 Follow us ... |
